Sirigen is a San Diego-based company that specializes in driving simple and cost-effective near patient testing through their innovative technology. Their high sensitivity fluorescence technology enables the analysis of multiple markers for diseases like HIV and leukemia, providing valuable information for early disease management. With a platform agnostic approach, Sirigen's materials can be easily integrated with a wide range of instrumentation and assays, making them adaptable for various diagnostic applications.
Powered by their High Sensitivity Fluorescence (HSF) technology, Sirigen's materials deliver enhanced signals, lower limits of detection, and improved multiplexing capabilities, offering greater confidence in test results. Their next-generation assays and performance-driven approach make Sirigen a leading brand in the field of diagnostics and research, providing adopters with a competitive edge and profitability.
Generated from the website